Abstract
Five days after arriving in London from Jos a young Nigerian women developed a severe and prolonged illness that proved to be Lassa fever. Virus was not detected in urine during the first three weeks but then appeared and reached a peak during the sixth week, with continuing excretion for 67 days after the onset of illness. Laboratory investigations showed evidence of extensive tissue damage and disturbance of clotting, but there was no serious bleeding and she eventually made a complete recovery despite a high sustained viraemia and severe liver damage. Convalescent serum was used in treatment but it was difficult to assess its contribution to the favourable outcome.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clayton A. J. Lassa immune serum. Bull World Health Organ. 1977;55(4):435–439. [PMC free article] [PubMed] [Google Scholar]
- Cooper C. B., Gransden W. R., Webster M., King M., O'Mahony M., Young S., Banatvala J. E. A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) 1982 Oct 9;285(6347):1003–1005. doi: 10.1136/bmj.285.6347.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galbraith N. S., Berrie J. R., Forbes P., Young S. Public health aspects of viral haemorrhagic fevers in Britain. R Soc Health J. 1978 Aug;98(4):152–160. doi: 10.1177/146642407809800407. [DOI] [PubMed] [Google Scholar]
- Keane E., Gilles H. M. Lassa fever in Panguma Hospital, Sierra Leone, 1973-6. Br Med J. 1977 May 28;1(6073):1399–1402. doi: 10.1136/bmj.1.6073.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leifer E., Gocke D. J., Bourne H. Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg. 1970 Jul;19(4):677–679. doi: 10.4269/ajtmh.1970.19.677. [DOI] [PubMed] [Google Scholar]
- Trexler P. C., Emond R. T., Evans B. Negative-pressure plastic isolator for patients with dangerous infections. Br Med J. 1977 Aug 27;2(6086):559–561. doi: 10.1136/bmj.2.6086.559. [DOI] [PMC free article] [PubMed] [Google Scholar]